Evolution of the type-1 (Th1)-type-2 (Th2) cytokine paradigm (Q33591470)

28 July 2017

1 reference

title

Evolution of the type-1 (Th1)-type-2 (Th2) cytokine paradigm (English)

1 reference

28 July 2017

Lucey DR

1

1 reference

28 July 2017

1 March 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

1

1 reference

28 July 2017

1-9, v

1 reference

Functional diversity of helper T lymphocytes

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Revisiting and revising suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

1 reference

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Two types of mouse helper T-cell clone Implications for immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

A Role for CD4+T-Cell Subsets Producing a Selective Pattern of Lymphokines in the Pathogenesis of Human Chronic Inflammatory and Allergic Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970039-8

7 January 2021

10.1016/S0891-5520(05)70039-8

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10198788